Post by Harvard Medical School

Michael A. Moskowitz, Harvard Medical School professor of neurology at Massachusetts General Hospital, has made multiple discoveries that have revolutionized thinking about migraine, deepened knowledge about why some treatments work, and led to new treatments that are available and prescribed now. As a postdoctoral fellow and junior faculty in the Harvard-MIT Health Sciences and Technology (HST) Program in the 1970s, he worked to enhance the understanding of the condition. He received the Brain Prize in 2021 for his contributions to migraine research. “My research has been 98 percent funded by the NIH over the course of my career,” Moskowitz said, expressing gratitude for the federal partnership that allowed bench-to-bedside medicine to flourish. “I can say with great confidence that if it weren’t for the NIH, we definitely wouldn’t have these new migraine drugs that block headaches.”